About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Organ, tissue and cell donation is one of the greatest acts of generosity and solidarity that an individual can do, and we strive to ensure that the maximum number of people benefit from it.
We are a multidisciplinary group of professionals who investigate the search for innovative strategies to optimize the process of donation, preservation, processing, and transplantation of organs, tissues and cells in order to increase their availability, expand their functionality, and improve their quality and safety, so they contribute to better health outcomes.
We deepen into the characterization of the damaging mechanisms that operate in the ischemia-reperfusion process during donation and transplantation in order to develop practices that allow us to prevent, minimize or treat them.
IP: Javier José Puig Galy
IP: José García Arumí Collaborators: Javier José Puig Galy, Anna Duarri Piqué, Ana Boixadera Espax, Claudia Garcia-Arumí Fusté, Miguel Angel Zapata Victori, Sara Martin Nalda, Laura Natalia Distefano Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 0.01 Reference: 2021 SGR 00994 Duration: 01/01/2022 - 30/06/2025
IP: Patologia Cel·lular Collaborators: Gema Ariceta Iraola, Alejandro Cruz Gual, Gerard Cantero Recasens, David Lorente García, Marina Muñoz López, Mercedes López González, Hector Rios Duro, Mónica Durán Fernández, Luis Augusto Castro Sáder, Gloria Mª Fraga Rodriguez, Julieta Torchia Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 40000 Reference: 2021 SGR 01600 Duration: 01/01/2022 - 30/06/2025
IP: Alberto Sandiumenge Camps Collaborators: Ernest Hidalgo Llompart, Jesús Quintero Bernabeu Funding agency: Ministerio de Ciencia e Innovación-MICINN Funding: 124939 Reference: CPP2021-008633 Duration: 01/09/2022 - 06/08/2025
IP: - Collaborators: - Funding agency: SOC.ESPAÑOLA NEUMOLOGIA CIRUGIA TORACICA Funding: 8370 Reference: SEPAR/PROJECTES/2020/BELLO Duration: 01/01/2022 - 31/12/2025
The work of the multinational team, which has reviewed the records of more than one million patients who have received a new organ, has found significant differences between women and men
Divuit hores de programa solidari recull més de 8 milions d'euros per lluitar contra les malalties del cor. A Catalunya, una de cada quatre persones moren a causa d'una malaltia del cor o un ictus
Els premiats són un projecte de simulació per entrenar-se en maneig d'ECMO, un programa d’entrenament de treball en equip amb simulació i una base de dades que permet registre i consulta del procés de donació d'òrgans i teixits en temps real.
